Navigation Links
MyClyns(TM), a New Standard of Personal Protection, is Announced at the EMS and Firehouse Central EXPO
Date:10/10/2007

Union Springs Pharmaceutical launches the only non-alcohol first response

protection product that can be sprayed on the face.

ORLANDO, Fla., Oct. 10 /PRNewswire/ -- Union Springs Pharmaceuticals, LLC, announced today at the annual EMS EXPO that it is marketing a new revolutionary product, MyClyns(TM). MyClyns is the first product of its kind to be made available to first responders who need to protect themselves in the field when exposed to harmful pathogens. The product, a small pen-sized non- aerosol spray device that can be kept in a pocket, is convenient and safe to use on the face and mucous membranes including the eyes, ears, nose, mouth, and skin. In addition, MyClyns is a fast-acting skin protectant that kills over 99.99% of germs on contact as demonstrated in independent laboratory tests. MyClyns also provides immediate efficacy after one application (>99% bacterial reduction) and passed the initial reduction criteria for the Health Care Personnel Handwash Test.

MyClyns contains a pH neutral, non-irritating solution of compounds that are similar to the chemicals produced by the human body in its defense against microorganisms. These compounds move through the pathogen's cells and deactivate essential enzymes and structures.

MyClyns allows first responders to protect themselves immediately after exposure to harmful pathogens while still attending to their care recipients. Since users can protect themselves immediately, they lower their risk associated with prolonged exposure. Because of its unique and convenient design, MyClyns can be used with only one hand. MyClyns is intended for use by police, fire, military, emergency medical personnel, healthcare providers, homeland security personnel and others.

Union Springs licensed worldwide rights to the Microcyn(R) Technology used in MyClyns for single-use first responder applications from Oculus Innovative Sciences, Inc. (Petaluma, CA) in June of this year.

"Our team at Union Springs is excited to be launching MyClyns at this year's EMS EXPO" said Roger Griggs, Chairman of Union Springs Pharmaceuticals. "We believe we have a truly unique product that first responders will use in situations where today there is nothing else available. We are happy to advance the science of personal protection and we hope that MyClyns will become the standard of care for first line responders after exposures where immediate attention is required," he added.

About Union Springs Pharmaceuticals, LLC

Union Springs Pharmaceuticals, located in Union, KY, specializes in providing innovative over-the-counter (OTC) products for the consumer and healthcare markets. The company licenses, acquires, develops and commercializes innovative products and technologies that satisfy the unmet needs of healthcare professionals and consumers. Union Springs Pharmaceuticals was formed by the Drug Enhancement Company of America (DECA) to commercialize products specifically targeted for the OTC market. DECA and members of its management team have developed both prescription and over-the-counter healthcare products and services and companies including Richwood Pharmaceuticals (now Shire), Xanodyne Pharmaceuticals, Integrity Pharmaceuticals, PediaMed and Hill Top Research. For more information about DECA, please visit http://www.decausa.com. Union Springs Pharmaceuticals can be found on the Internet at http://www.unionspringspharmaceuticals.com

Microcyn(R) is a registered trademark of Oculus Innovative Sciences, Inc.


'/>"/>
SOURCE Union Springs Pharmaceuticals, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Brinkmann/Eppendorf SOP Standard Operating Procedure for Pipettes
2. BioRobot MDx standardize your automated protocols in clinical laboratories
3. Thermal Cycling Profile for Standard PCR
4. Quantitative end-point RT-PCR gene expression measurement using the Agilent 2100 Bioanalyzer and standardized RT-PCR
5. Selection of Standards for Bio-Plex Cytokine Assays, Rev A
6. Universal Guide to DNA Standards
7. Verifying Multichannel Pipettor Performance with Standard Dispense Solutions in the SpectraMax Plus (MaxLine Application Note #28)
8. Accurate Evaluation of the Finnigan Surveyor Autosampler Performance using a Deferred Standard
9. Federal bill would set healthcare IT standards
10. Wisconsin firms pledge to support healthcare IT standards
11. Doyle, Kind call for higher renewable fuel standard
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Corporation (NASDAQ: VWR), the leading global independent provider of product ... its financial results for the fourth quarter and full year ... 4Q16 record quarterly net sales of $1.13 billion, up ... 4Q16 EMEA-APAC segment net sales increased ... net sales increased 2.5%, or down 0.9% on an organic ...
(Date:2/23/2017)... Feb. 23, 2017 /PRNewswire/ - The Fight Against Cancer ... Research (OICR) are pleased to report that Fusion Pharmaceuticals ... with Johnson & Johnson Innovation – JJDC, Inc. (JJDC) ... groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, as ... ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... de novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® Seizure ... at home or in healthcare facilities during periods of rest. A lightweight, non-invasive ...
Breaking Biology Technology:
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
Breaking Biology News(10 mins):